Vimarsana
Biggest News Aggregation in the World

Page 3 - Gene Correction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gene Correction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gene Correction Today - Breaking & Trending Today

Poseida Therapeutics Announces Multiple Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting - Vimarsana News

Poseida Therapeutics Announces Multiple Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with...

Chroma Medicine to Present First Data Demonstrating Promise of Its Epigenetic Editing Platform at 26th ASGCT Annual Meeting - Vimarsana News

Chroma Medicine to Present First Data Demonstrating Promise of Its Epigenetic Editing Platform at 26th ASGCT Annual Meeting

/PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced two oral...

Verve Therapeutics Announces Clearance of First VERVE-101 Clinical Trial Application and Outlines Global Clinical Development Strategy; Reports First Quarter 2022 Financial Results - Vimarsana News

Verve Therapeutics Announces Clearance of First VERVE-101 Clinical Trial Application and Outlines Global Clinical Development Strategy; Reports First Quarter 2022 Financial Results

10.05.2022 - Verve on Track to Begin Dosing HeFH Patients in New Zealand in Mid-2022 in a Phase 1 Clinical Trial with Initial Clinical Data Expected in 2023 Preparing for Submission of United Kingdom and United States Regulatory Filings for VERVE-101 in ...

EdiGene to Present getools, a Data Analysis Software Toolkit for Advanced Analytics of DNA and RNA E - Vimarsana News

EdiGene to Present getools, a Data Analysis Software Toolkit for Advanced Analytics of DNA and RNA E

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BEIJING and CAMBRIDGE, MASS. – (May 2, 2022) – EdiGene, Inc., a global, clinical-stage biotechnology company focused on translating gene-editing technologies into transformative therapies for patients with serious genetic diseases and cancer, will present getools (gene ed...

Precision BioSciences to Present Preclinical In Vivo Gene Editing Research at Upcoming American Soci - Vimarsana News

Precision BioSciences to Present Preclinical In Vivo Gene Editing Research at Upcoming American Soci

- Accepted abstracts to be presented as oral presentations and posters highlight preclinical development progress for ARCUS® gene editing therapiesDURHAM, N.C.--(BUSINESS WIRE)--$DTIL #ARCUS--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic...